CERSI-PGx provides a range of resources for researchers, clinicians, and regulators to support the understanding and implementation of pharmacogenomics. This includes guidelines, educational materials, and curated links to authoritative external platforms.

• Guidelines
• Educational Materials
• Publications
• External Resources

Guidelines

Access templates and published UK-based pharmacogenomic guidelines developed by WP1:

Published Guideline: MT-RNR1 Genotype testing for preventing aminoglycoside-mediated ototoxicity: a guideline

Published Guideline: UGT1A1 Genotype testing for irinotecan

Published Guideline: ACKR/Duffy-null genotype testing for clozapine

Published Guideline: HLA Genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine

Published Guideline: CYP2C19 Genotype Testing for Clopidogrel

Educational Materials

Training modules, slides, and learning resources created in collaboration with the British Pharmacological Society and other partners.

Featured Resources

• Free eLearning Portal Launched to Empower Healthcare Professionals with Genomic Literacy

Publications

Research articles, reports, and studies authored by CERSI-PGx and collaborating institutions:

We are delighted that WP5 article, “Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study” in The Pharmacogenomics Journal:

https://www.nature.com/articles/s41397-026-00425-1?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20260725&utm_content=10.1038/s41397-026-00425-1

We are pleased to share the publication of our paper, “Consistency and clarity of pharmacogenomic guidance in UK medicine patient information leaflets: A cross-sectional analysis,” in the British Journal of Clinical Pharmacology https://bpspubs.onlinelibrary.wiley.com/doi/10.1002/bcp.70521

The UK Industry PGx Regulatory Portal Product Discovery Report presents a comprehensive analysis and vision for a digital regulatory portal designed to streamline the compliance journey for pharmacogenomic (PGx) testing companies within the UK healthcare system. Developed through collaboration between JSOBrien Business Solutions Ltd and Blüm Health Ltd, and supported by the Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx), this white paper addresses the pressing need for a unified, authoritative platform to guide industry stakeholders through complex and fragmented regulatory requirements.

External Resources

Links to partner platforms, regulatory guidance, and industry-relevant portals.

Welcome to Genomics Education Programme – Genomics Education Programme

The UKCPA Handbook of Pharmacogenomics supports the use of pharmacogenetic results to optimise medicines by providing healthcare professionals with evidence-based advice and guidance in a simple and easy to use format:UKCPA Handbook of Pharmacogenomics | Expert medicines advice